From: The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Predictor
Average effect (SEM)
Between-donors SD of effect
Dexamethasone
8% (12%)
17%
Leflunomide × Etoricoxib
-8% (7%)
4%